In vitro cytotoxicity of carbon nanoparticles against Hep G 32 cells

The aim of the present study was to evaluate the in vitro toxicity of two multi wall carbon nanotubes (MWCNT) on human hepatocytes (Hep G 32 cell lines). The toxic effects of carbon nanoparticles were analyzed after 48 h of incubation with Hep G 32 cells using MTT assay and also estimated the levels of LDH (that is leakage into the media). The results of the LDH estimation demonstrated that exposure of multi wall carbon nanotubes to hepatocytes (Hep G 32) for 48 h resulted in concentration-dependent increase in LDH leakage and exhibited a significant (p 50 or IC50 values (toxic concentration 50 i.e. concentration of particles inducing 50 %cell mortality) of two nanoparticles were found in the range of 36.99-37.15 μg/ml, which were less than that of quartz (known toxic agent, 39.85 μg/ml), indicating the toxic nature of carbon nanoparticlesColegio de Farmacéuticos de la Provincia de Buenos Aire

Synthesis and Bronchodilator Studies of Some Novel 6-Alkyl/Aryl-1,2,4-Triazino[4,3-c]Quinazolines

A series of alkyl- and aryl-1,2,4-triazino[4,3-c]quinazolines (5a-h and 8a-h) were synthesized and characterized. The title compounds were evaluated for their in vivo bronchodilator activity on guinea pigs. All the test compounds exhibited good protection against histamine-induced bronchospasm. The structure-activity relationships based on the results obtained for these series were studied. Incorporation of an aryl ring with halo substitution to the theophylline bioisostere increases its potency. Among the compounds tested, 5b was found to be the most potent with 88.7% protection against histamine-induced bronchospasm compared to the standard compound aminophylline (87.8%)

Role of liver in progression of insulin resistance in relation to IGF-I and insulin levels in rats with acute hepatotoxicity

The aim of the present study was to investigate the role of liver in progression of insulin resistance in relation to IGF-I levels in rats with acute hepatotoxicity, induced by carbon tetrachloride (CCl4) and acetaminophen. Wistar rats were divided into four equal groups of six rats each. Group-I (served as Control1) received olive oil, group-II received CCl4, group-III (served as control 2) received gum acacia and group-IV received acetaminophen. After 48 h of treatment, fasting blood samples were collected to determine biochemical parameters, and liver and pancreas in all groups were collected for histological evaluations. The levels of serum fasting glucose, AST, ALT, ALP, total bilirubin and insulin resistance were Significantly more in group II & IV when compared with their respective control groups. Fasting insulin and IGF-I levels in toxicant treated groups were shown significantly lower than in control groups. The liver sections of toxicant treated rats showed hydropic degeneration (ballooning) in centrilobular hepatocytes with single cell necrosis surrounded by neutrophils. The serum IGF-I level could be a useful marker for identifying subjects at risk of developing type-II diabetes mellitus and possible cardiovascular complications.Colegio de Farmacéuticos de la Provincia de Buenos Aire

Fasting and Post Prandial Monitoring of Dipeptidyl Peptidase-Iv (Dpp-Iv) – A Biomarker To Assess Incretin Response In Type-2 Diabetes

Dipeptidyl peptidase-IV (DPP-IV) could serve as a potential biomarker in monitoring the disease progression and improvement on treatment. To investigate fasting & post prandial response of DPP-IV enzyme as indirect marker of incretin response failure after chronic treatment with metformin in type 2 diabetes. The study included twelve nondiabetic subjects, ten patients with glycosylated hemoglobin values (6-8 %) and fifteen patients with glycosylated hemoglobin greater than 8 % of type-2 diabetes patients of either sex with metformin treatment above 3 years were recruited. Fasting and post prandial DPP-IV levels were calculated. HbA1c was used to assess diabetes status. DPP-IV activity (fasting) in type 2 diabetic subjects with HbA1c> 8 % was significantly higher DPP-IV (44.67 ± 2.19 U/l) than in non diabetic subjects (24.39 ± 3.97 U/l). A significant correlation between DPP-IV (fasting / post prandial) and HbA1c (r = 0.821 & r = 0.732, P< 0.01) was observed in both diabetic (HbA1c 6-8, HbA1c < 8) patients. Hyperglycemia induces significant increase in serum DPP-IV activity in fasting condition and might contribute to the reduction in active glucagon like peptide-1(GLP-1) in type 2 diabetic subjects. In normal subjects during post prandial condition, there is sudden increase followed by decrease of GLP-1 due t